Adamax (5mg & 10mg)

Adamax is a synthetic nootropic peptide studied in cognitive and memory research models, synthesized and lyophilized in the USA under strict quality controls. Each production batch is purified by preparative HPLC and identity-confirmed by mass spectrometry, achieving purity above 99% with independent third-party certificates published per lot. Supplied as lyophilized powder for laboratory research use only.

Adamax (5mg & 10mg) is a lyophilized research peptide supplied for in-vitro laboratory investigation.

Studies of Adamax (5mg & 10mg) typically combine purity verification with functional assays to support reproducible results.

Researchers evaluating Adamax (5mg & 10mg) document batch COA data and storage conditions as part of experimental design.

This product is available in 5mg and 10mg. Each vial contains lyophilized peptide at the labeled quantity; wholesale orders are packed in boxes of ten vials at a single per-vial price.

Quality assurance: every batch is purified by reversed-phase high-performance liquid chromatography and identity-confirmed by mass spectrometry, with purity above 99%. Lot-specific certificates of analysis are available on request. Store lyophilized vials at -20°C, protected from light and moisture; reconstitute with bacteriostatic water immediately before use and avoid repeated freeze-thaw cycles. For in-vitro laboratory research use only — not for human or veterinary use.

Research & Literature

The following peer-reviewed studies and reference documents are commonly consulted by researchers working with Adamax (5mg & 10mg). Summaries are provided for orientation only and reflect the cited sources.

Peptide-Based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity^[1] — This review examined the molecular aspects underlying the biological activity of Selank, a heptapeptide with anxiolytic properties developed within the Russian regulatory peptide family. The authors discussed how the structural features of such heptapeptides contribute to their neurotropic and anxiolytic effects. The work provides background relevant to related nootropic peptides such as Adamax. (Protein and Peptide Letters 2018)

Natural and hybrid ('chimeric') stable regulatory glyproline peptides^[2] — This review explored the design and stabilization of naturally occurring and hybrid 'chimeric' regulatory glyproline peptides. It described strategies used to enhance the metabolic stability of short proline-containing peptides while preserving their regulatory activity. This framework is relevant to the chemical family from which Adamax-type nootropic peptides are derived. (Pathophysiology 2005)

References

1. Vyunova TV, Andreeva LA, Shevchenko KV, Myasoedov NF. "Peptide-Based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity." Protein and Peptide Letters. 2018. pubmed.ncbi.nlm.nih.gov/30255741/
2. Ashmarin IP, et al.. "Natural and hybrid ('chimeric') stable regulatory glyproline peptides." Pathophysiology. 2005. pubmed.ncbi.nlm.nih.gov/15837162/

All products are supplied as lyophilized powder for in-vitro laboratory research use only and are not for human or veterinary use.